Autres langues Biogen Inc.

Actions

BIIB

US09062X1037

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 15/07/2024			Varia. 5j.	Varia. 1 janv.
221,6 ^USD	-3,69 %		-2,85 %	-14,37 %

12/07	Biogen et Eisai obtiennent l'autorisation de Leqembi en Israël pour le traitement de la maladie d'Alzheimer	MT
11/07	Biogen et Eisai annoncent que Leqembi, un médicament contre la maladie d'Alzheimer, a obtenu l'autorisation de mise sur le marché à Hong Kong	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Final Deadline Approaching for Biogen Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Biogen Inc. (BIIB) Investors of July 22, 2024 Lead Plaintiff Deadline	15/07
July 22, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BIIB	15/07
Biogen, Eisai Get Approval for Leqembi in Israel for Treatment of Alzheimer's Disease	12/07
Eisai Co., Ltd. - LEQEMBI, Approved for the Treatment of Alzheimer's disease in Israel	12/07
Biogen Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BIIB	12/07
BIIB Investors Have Opportunity to Join Biogen Inc. Securities Fraud Investigation with the Schall Law Firm	11/07
Eisai Co., Ltd. - LEQEMBI Approved for the Treatment of Alzheimer's disease in Hong Kong	11/07
Biogen, Eisai Say Alzheimer's Drug Leqembi Secures Regulatory Approval in Hong Kong	11/07
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit	10/07
Biogen Inc. Sued for Securities Law Violations - Contact the Schall Law Firm to Discuss Your Legal Rights BIIB	10/07
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB	10/07
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen	10/07
Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB	10/07
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit	08/07
Shareholders that lost money on Biogen Inc.(BIIB) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More	08/07
BIIB Kessler Topaz Meltzer & Check, LLP Reminds Biogen Inc. (BIIB) Investors of Securities Fraud Class Action Lawsuit Filed On the Behalf	04/07
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen	03/07
July 22, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against BIIB	03/07
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit	03/07
US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments	02/07

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Biogen Inc.

Actions

BIIB

US09062X1037

Autres langues

Filtres